Institutional investors purchased a net $942.3 thousand shares of ADXS during the quarter ended July 2016. This may signal that the smart money is gaining interest in this company as the 60.96% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.3 Million shares of Advaxis Inc
EAM INVESTORS LLC Bought 379.7 Thousand shares of Advaxis Inc
BLACKROCK FUND ADVISORS Bought 325.7 Thousand shares of Advaxis Inc